Long-term tamoxifen treatment facilitates translocation of GPER to cell membranes, resulting in aberrant activation of the EGFR/ERK signaling pathway and upregulation of β1-integrin expression which is responsible for the enhanced communications between tumor cells and the tumor microenvironment (Fig. 8). The gene discussed is GPER1; the disease is neoplasm.